NovoSorb Breast Sling
Breast Reconstruction Surgery
Key Facts
About PolyNovo
PolyNovo is a commercial-stage medical device company with a mission to improve patient outcomes in complex wound management through its innovative NovoSorb® biodegradable polymer platform. Its key achievement is the successful global commercialization of NovoSorb BTM, a synthetic dermal substitute that addresses significant limitations of autografts and biological materials. The company's strategy focuses on expanding geographic reach, driving deeper market penetration in surgical wound care, and leveraging its polymer platform for new product development. PolyNovo is publicly traded on the ASX and has established a direct commercial presence in key markets including the US, Australia, and Europe.
View full company profile